Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Second patient to receive pig heart transplant dies | A big increase in IVL reimbursement | TAVR & cancer
Thursday, November 2, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Second patient in history to receive a pig heart transplant dies after 6 weeks

Lawrence Faucette, the second patient to ever receive a genetically modified pig heart, died on Oct. 30. “He can never be forgotten," his wife said in a statement. 

READ MORE >
Lawrence Faucette, the pig heart transplant patient who died after six weeks.
Share on Twitter Share on Facebook Share on Linkedin

Second patient in history to receive a pig heart transplant dies after 6 weeks

Share on Twitter Share on Facebook Share on Linkedin
Lawrence Faucette, the pig heart transplant patient who died after six weeks.
Lawrence Faucette, the second patient to ever receive a genetically modified pig heart, died on Oct. 30. “He can never be forgotten," his wife said in a statement. 
READ MORE >

IVL gains higher level of reimbursement with one of biggest coding updates for PCI in decades

Intravascular lithotripsy therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1.

READ MORE >
Intravascular lithotripsy (IVL) therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1. Illustration of the Shockwave lithoplasty procedure using sonic waves to bust calcium without trauma.
Share on Twitter Share on Facebook Share on Linkedin

IVL gains higher level of reimbursement with one of biggest coding updates for PCI in decades

Share on Twitter Share on Facebook Share on Linkedin
Intravascular lithotripsy (IVL) therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1. Illustration of the Shockwave lithoplasty procedure using sonic waves to bust calcium without trauma.
Intravascular lithotripsy therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1.
READ MORE >

TAVR patients with cancer face higher risks of hospital readmission, serious bleeding

Short-term mortality, however, does not appear to change when TAVR patients present with active cancer. 

READ MORE >
Doctor patient
Share on Twitter Share on Facebook Share on Linkedin

TAVR patients with cancer face higher risks of hospital readmission, serious bleeding

Share on Twitter Share on Facebook Share on Linkedin
Doctor patient
Short-term mortality, however, does not appear to change when TAVR patients present with active cancer. 
READ MORE >

Featured Articles

‘More dangerous than useful’: 1 in 5 coronary stents implanted by cardiologists are unnecessary, wasting $800M per year

A cardiologist-led think tank tracked data from more than 1 million procedures, exploring the clinical and economic impacts of implanting low-value coronary stents. 

READ MORE >
Patients receive unnecessary coronary stents during percutaneous coronary intervention (PCI) procedures at an alarming rate, according to a new report from the Lown Institute. The analysis included approximately 1 million stent procedures performed at more than 1,700 U.S. hospitals and outpatient facilities from 2019 to 2021.
Share on Twitter Share on Facebook Share on Linkedin

‘More dangerous than useful’: 1 in 5 coronary stents implanted by cardiologists are unnecessary, wasting $800M per year

Share on Twitter Share on Facebook Share on Linkedin
Patients receive unnecessary coronary stents during percutaneous coronary intervention (PCI) procedures at an alarming rate, according to a new report from the Lown Institute. The analysis included approximately 1 million stent procedures performed at more than 1,700 U.S. hospitals and outpatient facilities from 2019 to 2021.
A cardiologist-led think tank tracked data from more than 1 million procedures, exploring the clinical and economic impacts of implanting low-value coronary stents. 
READ MORE >

Coronary drug-coated balloon superior to standard of care for in-stent restenosis

Robert Yeh, MD, detailed the importance of the pivotal AGENT IDE trial, which focused on the use of a paclitaxel-coated balloon to treat in-stent restenosis. 

READ MORE >
Robert Yeh, MD, explains the details of the AGENT IDE trial clinical trial results for the Agent drug-coated balloon vs plain angioplasty for in-stent restenosis at TCT 2023. #TCT #TCT2023 #DCB
Share on Twitter Share on Facebook Share on Linkedin

Coronary drug-coated balloon superior to standard of care for in-stent restenosis

Share on Twitter Share on Facebook Share on Linkedin
Robert Yeh, MD, explains the details of the AGENT IDE trial clinical trial results for the Agent drug-coated balloon vs plain angioplasty for in-stent restenosis at TCT 2023. #TCT #TCT2023 #DCB
Robert Yeh, MD, detailed the importance of the pivotal AGENT IDE trial, which focused on the use of a paclitaxel-coated balloon to treat in-stent restenosis. 
READ MORE >

Google researchers use noise-canceling headphones to monitor heart health

The new technique, audioplethysmography, can monitor a user’s heart rate and other physiological signals using headphones equipped with active noice canceling technology. It requires no additional sensors.

READ MORE >
Image and caption courtesy of Google. APG sends a low intensity ultrasound transmitting wave (TX wave) using an ANC headphone's speakers and collects the receiving wave (RX wave) via the on-board feedback microphones. The APG signal is a pulse-like waveform that synchronizes with heartbeat and reveals rich cardiac information. Audioplethysmography Google headphones.
Share on Twitter Share on Facebook Share on Linkedin

Google researchers use noise-canceling headphones to monitor heart health

Share on Twitter Share on Facebook Share on Linkedin
Image and caption courtesy of Google. APG sends a low intensity ultrasound transmitting wave (TX wave) using an ANC headphone's speakers and collects the receiving wave (RX wave) via the on-board feedback microphones. The APG signal is a pulse-like waveform that synchronizes with heartbeat and reveals rich cardiac information. Audioplethysmography Google headphones.
The new technique, audioplethysmography, can monitor a user’s heart rate and other physiological signals using headphones equipped with active noice canceling technology. It requires no additional sensors.
READ MORE >

In Case You Missed It

Radial access shows potential to ‘revolutionize’ care for peripheral artery disease

Radial access provides interventional cardiologists with a safe, effective alternative to femoral access during peripheral artery interventions.

READ MORE >
surgery.jpg
Share on Twitter Share on Facebook Share on Linkedin

Radial access shows potential to ‘revolutionize’ care for peripheral artery disease

Share on Twitter Share on Facebook Share on Linkedin
surgery.jpg
Radial access provides interventional cardiologists with a safe, effective alternative to femoral access during peripheral artery interventions.
READ MORE >

Q&A: Ken Rosenfield explains the impact of new reimbursement coverage for carotid stenting 

Ken Rosenfield, MD, helped spearhead the recent Medicare policy change that made carotid stenting procedures available to more patients.

READ MORE >
Ken Rosenfield, MD, Mass General Hospital, explains the impact wider CMS reimbursement for carotid artery stenting will have on patient stroke care and interventional cardiology. CAS
Share on Twitter Share on Facebook Share on Linkedin

Q&A: Ken Rosenfield explains the impact of new reimbursement coverage for carotid stenting 

Share on Twitter Share on Facebook Share on Linkedin
Ken Rosenfield, MD, Mass General Hospital, explains the impact wider CMS reimbursement for carotid artery stenting will have on patient stroke care and interventional cardiology. CAS
Ken Rosenfield, MD, helped spearhead the recent Medicare policy change that made carotid stenting procedures available to more patients.
READ MORE >

In Other News

Radiologist dies after plane he was piloting crashes

Clifton Coffman, MD, practiced diagnostic radiology for more than 50 years, including serving as chief of the specialty at Willis-Knighton Medical Center.

READ MORE >
Gunman kills 4, including his former doctor, in Oklahoma hospital shooting.
Share on Twitter Share on Facebook Share on Linkedin

Radiologist dies after plane he was piloting crashes

Share on Twitter Share on Facebook Share on Linkedin
Gunman kills 4, including his former doctor, in Oklahoma hospital shooting.
Clifton Coffman, MD, practiced diagnostic radiology for more than 50 years, including serving as chief of the specialty at Willis-Knighton Medical Center.
READ MORE >

Covera Health earns $50M in funding, acquires radiology AI company

As part of the funding deal, Covera Health has finalized the acquisition of artificial intelligence vendor CoRead.

READ MORE >
According to calculations comparing catheter ablation with drug therapy, the additional quality-adjusted life-years that can result from the treatment justify its increased costs. 
Share on Twitter Share on Facebook Share on Linkedin

Covera Health earns $50M in funding, acquires radiology AI company

Share on Twitter Share on Facebook Share on Linkedin
According to calculations comparing catheter ablation with drug therapy, the additional quality-adjusted life-years that can result from the treatment justify its increased costs. 
As part of the funding deal, Covera Health has finalized the acquisition of artificial intelligence vendor CoRead.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup